| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Null Results in Brief |
1 Division of Cancer Epidemiology and Genetics, 2 Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland; 3 Magee-Womens Research Institute, 4 Department of Obstetrics Gynecology and Reproductive Sciences, 5 Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania; and 6 University of California San Francisco School of Medicine, San Francisco, California
Reductions in breast cancer risk observed in daughters of pre-eclamptic pregnancies are hypothesized to be mediated by lower in utero estrogen concentrations. Whereas maternal urinary estriol excretion is generally lower in pre-eclamptic women, results for maternal blood concentrations are equivocal, and little is known about estrogen concentrations in the cord of pre-eclamptic pregnancies. Unconjugated estrogen and androgen concentrations were measured in mixed umbilical cord sera from 86 pre-eclamptic and 86 uncomplicated, singleton pregnancies, matched on length of gestation, maternal age, parity, and type of delivery. Pre-eclamptic and uncomplicated pregnancies were similar in maternal age, prepregnancy weight, maternal height, type of delivery, use and type of anesthesia, and sex of offspring. Estriol, estradiol, estrone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, androstenedione, and testosterone concentrations measured in cord sera were not significantly different in pre-eclamptics compared with uncomplicated pregnancies. Estriol was 9% lower (P = 0.43), and all of the other hormones were actually higher in pre-eclamptics with testosterone and estradiol approaching statistical significance (P = 0.06 and P = 0.12, respectively). These data do not support the hypothesis that the lower breast cancer risk in daughters of pre-eclamptic pregnancies is explained by lower in utero estrogen exposure.
This article has been cited by other articles:
|
|
 |
|
  R. Troisi, P. Lagiou, D. Trichopoulos, B. Xu, L. Chie, F. Z. Stanczyk, N. Potischman, H.-O. Adami, R. N. Hoover, and C.-C. Hsieh Cord Serum Estrogens, Androgens, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 in Chinese and U.S. Caucasian Neonates Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Troisi, L. Vatten, R. N. Hoover, J. M. Roberts, B. F. Cole, and N. Potischman Maternal androgen and estrogen concentrations are not associated with blood pressure changes in uncomplicated pregnancies. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 2013 - 2015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Palmer, L. A. Wise, E. E. Hatch, R. Troisi, L. Titus-Ernstoff, W. Strohsnitter, R. Kaufman, A. L. Herbst, K. L. Noller, M. Hyer, et al. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1509 - 1514. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
